INTRODUCTION
Various organic solvents are known to produce depressive effects on the central nervous system (CNS) as a common character.1) Quantitative evaluation of subjective symptoms as an expression of the CNS effects, however, has been conducted only on limited occasions2-7) probably because of technical difficulties.8) In recent years, attention has been paid on the validity of subjective symptom questionnaires as a method of group diagnosis to detect excess exposure to industrial solvents.9) It has also been known through experiences that the prevalence of subjective symptoms are influenced by emotional factors as well as social habits such as smoking.10)
The subjective symptoms were surveyed in the present study in a group of solvent workers who were nondrinkers-nonsmokers and homogeneous regarding sex and age so that common confounding factors were expected to be ruled out mostly, and the prevalence was evaluated in comparison with the intensity of exposure to the solvent to examine whether there is a quantitative dose-response relationship. The workers were shoe-makers almost exclusively exposed to toluene, the most popular solvent11,12) for which an occupational exposure limit of 100 ppm is proposed primarily based on the evaluation of CNS effects.13,14)
MATERIALS AND METHODS
Subjects and factories studied. The subjects studied (258 in total) were nonsmoking-nondrinking Korean women at 16 to 44 years of age (mostly at 20's). The solvent workers (193 subjects) were shoe-makers, and they were exposed to solvent vapor as they applied glue to the materials. Workroom air analysis disclosed that the major solvent in air was toluene, and the levels of other solvents (n-hexane, cyclohexane and methyl ethyl ketone) as a whole were less than one tenth of that of toluene. Remaining 65 women had no exposure to solvents and served as non-exposed controls. The duration of the work was recorded in the interview.
Measurement of exposure to toluene.
The 8-hour time-weighted average concentration of toluene in breath zone air of each individual was measured by diffusive sampling method, and the values are cited from a previous report.15 ' The information available indicated that the workers repeated same work everyday and that the production rate was rather stable for the preceding months.
Subjective symptom survey. For the survey of subjective symptoms, a selfcompleted questionnaire set proposed by Inoue9) for organic solvent workers was employed. The original set carries 12 questions in Part 1 (on the subjective symptoms during work) and 54 questions in Part 2 (on the subjective symptoms in past 6 months when out of workshops); Table  2 ). The examination of the difference in the prevalence between the low-exposed (i.e., exposed to toluene at •… 100 ppm) and the high-exposed (exposed The symptoms depicted are those whose difference in the prevalence between the 100 ppm group and the >100 ppm group is highly significant (p<0.05) (see Column C in Table 2 ), together with Nos. 2, 3 and 5 (headache, dizziness and sore throat) as the increases of which were significant in a preceding study.7) The case of Symptom No. 23 is shown in Fig. 3 .
Other types of dose-prevalence relationship
Further analyses of prevalence of other symptoms in relation to the exposure intensity disclosed three types of response (Fig. 3) in addition to the deck chair type shown in Fig. 2 . As depicted in the top in Fig. 3 , the prevalence of joint pain or dullness in extremities (Symptoms No. 44. and 23., respectively) increases linear to toluene concentration and no inflection point appeared to exist. In the cases of reduced sense of taste and proneness to stumble during walk (in the middle in Fig. 3) , there was no significant changes at the levels below 150 ppm Fig. 3 . Three types of response in subjective symptom prevalence with increase in exposure intensity. The top, middle and bottom figures show the cases with a linear increase in subjective symptom prevalence, those with little change up to 150 ppm followed by a marked increase at the higher concentrations, and those with essentially no response at any exposure concentrations studied, respectively. and the increase took place only in the highest concentration range. Finally, there was no significant changes in the prevalence of loose bowels (No. 28.) nor loss of consciousness (No. 12.) at any toluene concentrations studied (in the bottom in Fig. 3) . The last observation is apparently natural because the gastrointestinal tract is not known to be the target of toluene toxicity and no fainted woman was found during work in the factories surveyed.
DISCUSSION
In controlled human volunteer studies with toluene, von Oettingen et al.17) exposed themselves to toluene vapors 8 hour a day, twice a week for 3 months and experienced very mild headache at 50 ppm, moderate fatigue and slight headache at 100 ppm, and repeated headache, nausea, muscular weakness, confusion and dermal paresthesia together with such signs as dilation of pupils at 200 pm. Later, Andersen et al.18) reorted that there was a statistically significant increase in the occurrence of headache, dizziness and feeling of intoxication (but not nausea nor coughing) among 16 subjects exposed for 6 hours at 100 ppm, that 10 subjects out of the 16 experienced slight irritation in the nose and the eyes (but not in the throat nor the lower airways) at this concentration and that such symptoms were not reported at lower concentrations (i.e., 10 or 40 ppm). Iregren19) observed that the prevalence of CNS-related subjective symptoms such as headache, dizziness and tiredness increased significantly after 4-hour exposure to toluene at 80 ppm. The findings as a whole suggest that the prevalence of subjective symptoms will be related to the intensity of exposure to toluene and will carry occupational health significance.
Based on factory surveys, Wilson20) concluded that headache, lassitude and loss of appetite were observed at 50 to 200 ppm, and complaints (including headache, nausea, bad taste in mouth, anorexia and lassitude) were more numerous and pronounced at 200 to 500 ppm. It should, however, be noted that the judgement of exposure intensity was not strictly objective due to technical limitation of the time. Matsushita et al:.4) studied on 38 female shoe-makers exposed to toluene in a range of 10-200 ppm, and found that complaints such as general weakness, fatigue, lassitude, dysmenorrhea and abnormal tendon reflexes were more frequent in the exposed workers than in the controls. In a study of painters exposed to solvent mixture vapors including toluene at 3-10 ppm, Elofsson et al.21) observed a significant increase in the prevalence of various symptoms such as headache, feeling of intoxication, dry skin, frequent expectoration, dyspnoea, fatigue, reduced memory, absentmindedness, muscular weakness, paresthesia and muscular pains in the extremities. Hanninen et al.22) reported impairments in visual intelligence and verbal memory, and reduction in emotional reactivity after the examination of car painters exposed for years to solvent mixtures in which toluene was present at 31 ppm as a mean. According to Coscia et al.,23) they found that vestibular function was altered among rotogravure printers exposed to toluene at 100-110 ppm. No dose-response analysis could be made in any of these studies, however, possibly because the diffusive sampling technique, the most practical method for personal sampling in solvent work place, was developed in 1980's24) and was not yet available in early days.
In succession to the preliminary observation in a preceding study4) that complaints of sore throat, headache and probably dizziness increased as a function of benzene (1-40 and 41-210 ppm) and toluene (6-39 and 40-123 ppm) concentrations in breath zone air, the present study has clearly demonstrated that there exists a dose-response relationship in the prevalence of subjective symptoms among the workers exposed to toluene at below and above current occupational exposure limit of 100 ppm.13,14,16) It is further observed that an inflection point may possibly be present at around 100 ppm for the increase in prevalence of some symptoms (Fig. 2) , which is in accordance with the current occupational exposure limit for toluene of 100 ppm, although the findings do not necessarily prove the safety of exposure below this level because the prevalence of some other symptoms is linearly related to the dose (Fig. 3) .
While dose-dependent increase in subjective symptom prevalence within the exposed subjects may suggest the validity of the symptom survey as a tool to detect solvent toxicity, the relatively large elevation in the lowest-exposed (i.e., 1-50 ppm) group over the non-exposed worth attention. Grasso et al.8) in their critical review on solvent symptomatology studies pointed out that the differences in the incidence of the observed symptoms could possibly reflect the differences in the total working environment including stresses rather than in the exposure to solvents. Such may explain the elevation at least in part in the present study, as no particular efforts were made to match the workplace conditions and stresses arising from the workroom environment between the exposed and the controls. In this sense, the present observation should be taken yet preliminary. As the quantitative statistical analysis of subjective symptoms in relation to the exposure intensity is quite important in evaluation of the CNS-affecting chemicals such as toluene, arrangements are currently in progress in our laboratories to carry out similar factory surveys of a expanded scale on toluene wokers to examine the reproducibility of the present observation and, if possible, to identify marker symptoms at various levels of toluene exposure and threshold exposure concentrations for some symptoms.
